EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The Present and Future of Lipid Testing in Cardiovascular Risk Assessment

Nicole M A White-Al Habeeb, Victoria Higgins, Anna Wolska iD, Sarah R Delaney, Alan T Remaley, Daniel R Beriault iD

Clinical Chemistry · 2023

DOI: 10.1093/clinchem/hvad012 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Chemistry, 2023. Verfasst von Nicole M A White-Al Habeeb und 5 weiteren Autor:innen. Beteiligte Einrichtung: Dynacare, Brampton, ON, Canada. Hauptthemen laut MEDLINE: Cardiovascular Diseases. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 78 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background Lipids play a central role in the pathogenesis of cardiovascular disease (CVD), a leading cause of morbidity and mortality worldwide. Plasma lipids and lipoproteins are routinely measured to help identify individuals at high risk of developing CVD and to monitor patients’ response to therapy. The landscape of lipid testing is rapidly changing, including new ways to estimate traditional lipid parameters (e.g., low-density lipoprotein-cholesterol [LDL-C] calculations) and new lipid parameters that show superiority for risk prediction (e.g., non-high-density lipoprotein-cholesterol [non-HDL-C], apolipoprotein B [apoB], and lipoprotein a [Lp(a)]). Content Various national guidelines for managing dyslipidemia to prevent CVD are available, which primarily focus on LDL-C for identifying those at high risk and setting thresholds for optimal response to therapy. However, LDL-C can be calculated and measured in various ways, each with advantages and disadvantages. Importantly, the recently established Sampson–NIH LDL-C equation appears to be superior to preceding calculations, as is clear from the literature and in guidelines. There is now a shift towards using lipid parameters other than LDL-C, such as non-HDL-C, apoB, and Lp(a), to identify high-risk patients and/or establish treatment targets. Summary The goal of this review is to discuss the present and future of lipid testing for CVD risk assessment through describing various national clinical guidelines, critically reviewing methods to calculate and measure LDL-C and discussing the clinical utility of additional lipid parameters.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesHumansCholesterol, LDLRisk FactorsCholesterolRisk AssessmentApolipoproteins BLipoproteinsHeart Disease Risk FactorsCholesterol, HDL

Substanzen

Cholesterol, LDLCholesterolApolipoproteins BLipoproteinsCholesterol, HDL

Autor:innen und Institutionen

  • Dynacare, Brampton, ON, Canada.
  • DynaLIFE Medical Labs, Edmonton, AB, Canada.
  • Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, AB, Canada.
  • Lipoprotein Metabolism Laboratory, Translational Vascular Medicine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, United States.
  • Department of Laboratory Medicine, Unity Health Toronto, Toronto, ON, Canada.
  • Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.

ORCID-Profile: Anna Wolska, Daniel R Beriault

Zitieren

APA

White-Al Habeeb, N. M. A., Higgins, V., Wolska, A., Delaney, S. R., Remaley, A. T., & Beriault, D. R. (2023). The Present and Future of Lipid Testing in Cardiovascular Risk Assessment. Clinical Chemistry. https://doi.org/10.1093/clinchem/hvad012

Vancouver

White-Al Habeeb NMA, Higgins V, Wolska A, Delaney SR, Remaley AT, Beriault DR. The Present and Future of Lipid Testing in Cardiovascular Risk Assessment. Clinical Chemistry. 2023. doi:10.1093/clinchem/hvad012

BibTeX
@article{WhiteAlHabeeb2023,
  author = {White-Al Habeeb, Nicole M A and Higgins, Victoria and Wolska, Anna and Delaney, Sarah R and Remaley, Alan T and Beriault, Daniel R},
  title = {The Present and Future of Lipid Testing in Cardiovascular Risk Assessment},
  journal = {Clinical Chemistry},
  year = {2023},
  doi = {10.1093/clinchem/hvad012}
}
Kostenlos starten →